share_log

T2 Biosystems | 4: Statement of changes in beneficial ownership of securities-10% Owner CR Group L.P.

SEC ·  May 14 06:24
Summary by Futu AI
CR Group L.P., a significant shareholder in T2 Biosystems, Inc. [TTOO], reported acquiring a total of 1,823,800 shares of common stock on May 9, 2024. The transactions were made indirectly through CRG Partners III - Parallel Fund B (Cayman) L.P. Following these acquisitions, CR Group L.P. now holds a total of 4,704,729 shares in the company. The shares were acquired with the transaction code 'C', indicating that these were not open market transactions. The total number of shares held by CR Group L.P. before these transactions was 9,300,706. The nature of the shares is indirect, and the specific transaction prices were not disclosed in the announcement.
CR Group L.P., a significant shareholder in T2 Biosystems, Inc. [TTOO], reported acquiring a total of 1,823,800 shares of common stock on May 9, 2024. The transactions were made indirectly through CRG Partners III - Parallel Fund B (Cayman) L.P. Following these acquisitions, CR Group L.P. now holds a total of 4,704,729 shares in the company. The shares were acquired with the transaction code 'C', indicating that these were not open market transactions. The total number of shares held by CR Group L.P. before these transactions was 9,300,706. The nature of the shares is indirect, and the specific transaction prices were not disclosed in the announcement.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.